Skip to content

difference of intravenous versus nebulised dexmedetomidine for attenuation of sympathetic response to laryngoscopy & endotracheal intubation

a comparative study of intravenous v/s nebulised dexmedetomidine for attenuation of pressor response to laryngoscopy & endotracheal intubation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054006
Enrollment
60
Registered
2023-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R098- Other specified symptoms and signsinvolving the circulatory and respiratory systems

Interventions

Intervention1: Dexmedetomidine nebulized v/s intravenous - 1 microgram per kg body weight of the patient will be given by either nebulization route or by intravenous route 30 minutes before induction.

Sponsors

Somya Pareek
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA grades 1 & 2 (American Society of Anesthesiologists physical status) 2.Age group 18- 65 years 3.Either gender 4.Patients scheduled for elective surgery under general anaesthesia with endotracheal intubation Patients fulfilling the above criteria consenting to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Patient refusal. 2.Patients less than 18 years and more than 65 years of age. 3.Patients scheduled for general anaesthesia without endotracheal intubation such as mask ventilation, use of laryngeal mask airways, sedation, monitored anaesthetic care, or surgery duration more than 90mins. 4.Patients coming for surgery under regional anaesthesia. 5.Patients belonging to ASA grade >= III. 6.Patients undergoing emergency surgeries. Obese individuals (body mass index > 30 kg/m2) 7.Patients with known or unanticipated difficult intubation and those requiring more than 15secs or two attempts at laryngoscopy. 8.Patients with arrythmias. 9.Patients with known allergy to dexmedetomidine, and those on anti-hypertensive medications or preoperative drugs that could be potential confounders (clonidine, gabapentin, pregabalin, steroids)

Design outcomes

Primary

MeasureTime frame
SBP,DBP, SpO2, MAP, HRTimepoint: baseline, After giving, immediately after intubation, after 1 min, following 3 min, 5 min, 7 min, 10 min,15 min,30 min, 45 min, 60 min, 90 min

Secondary

MeasureTime frame
Post operative sore throat, analgesic dose requirements, sedationTimepoint: baseline, After giving, immediately after intubation, after 1 min, following 3 min, 5 min, 7 min, 10 min,15 min,30 min, 45 min, 60 min, 90 min

Countries

India

Contacts

Public ContactDr Tejinder Singh Ajmani

Peoples College of medical sciences and research centre

drmahimabatra@gmail.com9752075418

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026